Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
Appointed director
|
|
Surface Oncology, Inc. (SURF)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/14/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 9.9% stake in Surface Oncology, Inc. |
| 02/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/10/2020 |
SC 13G
| FMR LLC reports a 5% stake in SURFACE ONCOLOGY INC |
| 05/29/2020 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.8% stake in Surface Oncology, Inc. |
| 05/29/2020 |
SC 13G
| EcoR1 Capital, LLC reports a 12.8% stake in Surface Oncology, Inc. |
| 05/29/2020 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 9.9% stake in Surface Oncology, Inc. |
| 02/14/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2019 |
SC 13G
| Atlas Venture Fund IX, L.P. reports a 16.8% stake in SURFACE ONCOLOGY, INC. |
| 11/13/2018 |
SC 13G
| EcoR1 Capital, LLC reports a 6.3% stake in Surface Oncology, Inc. |
| 04/25/2018 |
SC 13G
| FMR LLC reports a 11.4% stake in SURFACE ONCOLOGY INC |
| 04/23/2018 |
SC 13G
| Novartis Institutes for BioMedical Research, Inc. reports a 14.3% stake in Surface Oncology, Inc. |
|
|